FLOLAN Side Effects

6144671-0 |
on Mar 30, 2009 Male patient from FRANCE , 73 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Flolan (View Usage). . Flolan dosage: .

6144639-4 | Pulmonary Hypertension, Splenomegaly
Patient was taking Flolan (View Usage). Patient had the following side effects: pulmonary hypertension (What is pulmonary hypertension?), splenomegaly on Mar 30, 2009 from UNITED STATES Additional patient health information: Female patient , 67 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Flolan dosage: . During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), LASIX (View Lasix Review and Lasix Label ), REVATIO (View Revatio Review and Revatio Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6126184-5 | Autoimmune Disorder
Adverse event was reported on Mar 13, 2009 by a Female patient taking Flolan (View Usage) (Dosage: ) was diagnosed with arterial disorder and. Location: AUSTRIA , 23 years of age, After Flolan was administered, patient had the following side effects: autoimmune disorder.

6124623-7 | Pulmonary Congestion
on Mar 16, 2009 Male patient from JAPAN , 55 years of age, weighting 136.7 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), right ventricular failure and was treated with Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary congestion. Flolan dosage: . During the same period patient was treated with WARFARIN POTASSIUM (4mg Per Day) (View Warfarin Potassium Review and Warfarin Potassium Label ), FUROSEMIDE (40mg Per Day) (View Furosemide Review and Furosemide Label ).


6124608-0 |
on Mar 17, 2009 Male patient from CANADA , 36 years of age, was treated with Flolan (View Usage). . Flolan dosage: . Patient was hospitalized.

6109431-5 | Anorexia, Catheter Related Infection, Catheter Site Pain, Diarrhoea, Nausea, Oesophageal Hypomotility, Purulent Discharge, Pyrexia, Staphylococcal Infection
Patient was taking Flolan (View Usage). After Flolan was administered, patient had the following side effects: anorexia, catheter related infection, catheter site pain, diarrhoea, nausea (What is nausea?), oesophageal hypomotility, purulent discharge, pyrexia, staphylococcal infection (What is staphylococcal infection?) on Mar 06, 2009 from JAPAN Additional patient health information: Female patient , 34 years of age, weighting 114.6 lb, was diagnosed with mixed connective tissue disease and. Flolan dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), PARIET (View Pariet Review and Pariet Label ), BIOFERMIN (View Biofermin Review and Biofermin Label ), GASCON (View Gascon Review and Gascon Label ). Patient was hospitalized.

6101727-6 |
Adverse event was reported on Mar 03, 2009 by a Male patient taking Flolan (View Usage) (Dosage: ) . Location: CANADA , 67 years of age, weighting 161.4 lb, .

6098868-9 | Pulmonary Congestion
on Feb 27, 2009 Male patient from JAPAN , 55 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Flolan (View Usage). Patient had the following side effects: pulmonary congestion. Flolan dosage: . During the same period patient was treated with WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

6097242-9 | Atrial Fibrillation
on Feb 24, 2009 Female patient from JAPAN , 28 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Flolan (View Usage). After Flolan was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). Flolan dosage: . During the same period patient was treated with LAC B (View Lac B Review and Lac B Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), TRACLEER (View Tracleer Review and Tracleer Label ), DIART (View Diart Review and Diart Label ), REVATIO (View Revatio Review and Revatio Label ), ALLEGRA (View Allegra Review and Allegra Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ). Patient was hospitalized.

6093979-6 | Condition Aggravated, Hypoxia, Interstitial Lung Disease, Pulmonary Oedema
Patient was taking Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, hypoxia, interstitial lung disease, pulmonary oedema on Feb 20, 2009 from JAPAN Additional patient health information: Female patient , child 3 years of age, weighting 20.28 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Flolan dosage: . During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ).

6082184-5 | Syncope
Adverse event was reported on Feb 12, 2009 by a Female patient taking Flolan (View Usage) (Dosage: ) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: CANADA , 16 years of age, Patient had the following side effects: syncope.

6071031-3 | Catheter Related Infection, Catheter Site Erythema, Catheter Site Pain, Diarrhoea, Pyrexia
on Feb 06, 2009 Female patient from JAPAN , 44 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Flolan (View Usage). After Flolan was administered, patient had the following side effects: catheter related infection, catheter site erythema, catheter site pain, diarrhoea, pyrexia. Flolan dosage: . During the same period patient was treated with CRAVIT (View Cravit Review and Cravit Label ).

6066621-8 | Anaemia, Hypotension
on Feb 04, 2009 Female patient from JAPAN , 67 years of age, weighting 74.96 lb, was diagnosed with mixed connective tissue disease and was treated with Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, hypotension. Flolan dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ). Patient was hospitalized.

6053317-1 | Pulmonary Arterial Hypertension
Patient was taking Flolan (View Usage). Patient had the following side effects: pulmonary arterial hypertension on Jan 26, 2009 from CANADA Additional patient health information: Female patient , 68 years of age, was diagnosed with pulmonary arterial hypertension and. Flolan dosage: 3mg Per Day.

6051576-2 |
Adverse event was reported on Jan 13, 2009 by a Male patient taking Flolan (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: FRANCE , 73 years of age, .

6048483-8 | Pulmonary Hypertension, Splenomegaly
on Jan 20, 2009 Female patient from UNITED STATES , 67 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary hypertension (What is pulmonary hypertension?), splenomegaly. Flolan dosage: . During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), DIGITEK (View Digitek Review and Digitek Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), LASIX (View Lasix Review and Lasix Label ), REVATIO (View Revatio Review and Revatio Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6041583-8 |
on Jan 15, 2009 Female patient from CANADA , 50 years of age, weighting 138.9 lb, was treated with Flolan (View Usage). . Flolan dosage: .

6028769-3 | Basedow's Disease, Cardiac Failure, Catheter Related Complication, Goitre, Hyperthyroidism, Neck Pain, Tachycardia
Patient was taking Flolan (View Usage). After Flolan was administered, patient had the following side effects: basedow's disease, cardiac failure, catheter related complication, goitre, hyperthyroidism, neck pain, tachycardia on Dec 30, 2008 from JAPAN Additional patient health information: Female patient , child 9 years of age, was diagnosed with pulmonary arterial hypertension and. Flolan dosage: . During the same period patient was treated with WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), PERSANTINE (View Persantine Review and Persantine Label ), RENIVACE (View Renivace Review and Renivace Label ), VIAGRA (View Viagra Review and Viagra Label ). Patient was hospitalized.

6027362-6 | Pulmonary Congestion
Adverse event was reported on Dec 29, 2008 by a Male patient taking Flolan (View Usage) (Dosage: ) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: JAPAN , 55 years of age, Patient experienced the following unwanted or unexpected effects: pulmonary congestion.

6023155-4 | Anaemia, Cardiac Failure, Oedema, Pallor, Palpitations, Tachycardia, Thyroid Disorder, Weight Increased
on Dec 29, 2008 Female patient from JAPAN , 15 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), pulmonary arterial hypertension and was treated with Flolan (View Usage). Patient had the following side effects: anaemia, cardiac failure, oedema, pallor, palpitations, tachycardia, thyroid disorder, weight increased. Flolan dosage: . During the same period patient was treated with WARFARIN POTASSIUM (1mg Per Day) (View Warfarin Potassium Review and Warfarin Potassium Label ), FUROSEMIDE (60mg Per Day) (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (75mg Per Day) (View Spironolactone Review and Spironolactone Label ), DIGOXIN (.25mg Per Day) (View Digoxin Review and Digoxin Label ), SALOBEL (50mg Per Day) (View Salobel Review and Salobel Label ), RENIVACE (2.5mg Per Day) (View Renivace Review and Renivace Label ), VIAGRA (View Viagra Review and Viagra Label ), MYSLEE (View Myslee Review and Myslee Label ). Patient was hospitalized and became disabled.

6017990-6 | Cellulitis, Diarrhoea, Gamma-glutamyltransferase Increased, Hypoalbuminaemia, Isolated Adrenocorticotropic Hormone Deficiency, Right Ventricular Failure, Weight Increased
on Dec 19, 2008 Female patient from JAPAN , 24 years of age, was diagnosed with pulmonary thrombosis and was treated with Flolan (View Usage). After Flolan was administered, patient had the following side effects: cellulitis (What is cellulitis?), diarrhoea, gamma-glutamyltransferase increased, hypoalbuminaemia, isolated adrenocorticotropic hormone deficiency, right ventricular failure, weight increased. Flolan dosage: . During the same period patient was treated with SILDENAFIL CITRATE (View Sildenafil Citrate Review and Sildenafil Citrate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ALBUMIN (HUMAN) (View Albumin (human) Review and Albumin (human) Label ), FULCALIQ (View Fulcaliq Review and Fulcaliq Label ), CORTRIL (View Cortril Review and Cortril Label ). Patient was hospitalized.

6006334-1 | Cardiac Failure, Chest Pain, Loss Of Consciousness, Pulmonary Oedema, Vomiting
Patient was taking Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, chest pain (What is chest pain?), loss of consciousness, pulmonary oedema, vomiting on Dec 12, 2008 from SPAIN Additional patient health information: Female patient , 19 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), upper respiratory tract infection and. Flolan dosage: . During the same period patient was treated with AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ).

6000079-X | Basedow's Disease, Cardiac Failure, Catheter Related Infection, Catheter Removal, Condition Aggravated, Haemoptysis, Pseudomonas Infection, Pulmonary Haemorrhage, Right Ventricular Failure
Adverse event was reported on Dec 05, 2008 by a Female patient taking Flolan (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: JAPAN , 14 years of age, weighting 92.59 lb, Patient had the following side effects: basedow's disease, cardiac failure, catheter related infection, catheter removal, condition aggravated, haemoptysis, pseudomonas infection, pulmonary haemorrhage, right ventricular failure. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), SLOW K (View Slow-k Review and Slow-k Label ), MEDICON (View Medicon Review and Medicon Label ), FERO GRADUMET (View Fero-gradumet Review and Fero-gradumet Label ), CINAL (View Cinal Review and Cinal Label ). Patient was hospitalized.

5987038-8 | Cardiac Failure, Chest Pain, Loss Of Consciousness, Pulmonary Oedema, Vomiting
on Dec 04, 2008 Female patient from SPAIN , 18 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), respiratory disorder and was treated with Flolan (View Usage). After Flolan was administered, patient had the following side effects: cardiac failure, chest pain (What is chest pain?), loss of consciousness, pulmonary oedema, vomiting. Flolan dosage: . During the same period patient was treated with AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ).

5982259-2 |
on Dec 04, 2008 Female patient from CANADA , weighting 127.2 lb, was diagnosed with pulmonary arterial hypertension and was treated with Flolan (View Usage). . Flolan dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ). Patient was hospitalized.

5972554-5 | Atrial Fibrillation, Bradycardia, Hyperhidrosis, Hypotension, Vomiting
Patient was taking Flolan (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), bradycardia, hyperhidrosis, hypotension, vomiting on Nov 25, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 54 years of age, weighting 169.8 lb, . Flolan dosage: . During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), NAFTIDROFURYL OXALATE (View Naftidrofuryl Oxalate Review and Naftidrofuryl Oxalate Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), HUMALOG (View Humalog Review and Humalog Label ).

5972552-1 | Catheter Related Infection, Erythema, Folliculitis, Rash Vesicular
Adverse event was reported on Nov 24, 2008 by a Male patient taking Flolan (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: FRANCE , 59 years of age, weighting 257.9 lb, After Flolan was administered, patient had the following side effects: catheter related infection, erythema, folliculitis, rash vesicular. During the same period patient was treated with SERETIDE (View Seretide Review and Seretide Label ), TAHOR (View Tahor Review and Tahor Label ), ZESTRIL (View Zestril Review and Zestril Label ), DEPAKINE 500 (View Depakine 500 Review and Depakine 500 Label ), COUMADIN (View Coumadin Review and Coumadin Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), BURINEX (View Burinex Review and Burinex Label ). Patient was hospitalized.

5965738-3 | Goitre, Hyperthyroidism, Supraventricular Tachycardia
on Nov 20, 2008 Female patient from JAPAN , 42 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: goitre, hyperthyroidism, supraventricular tachycardia. Flolan dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (25mg Per Day) (View Spironolactone Review and Spironolactone Label ), DIGOXIN (.25mg Per Day) (View Digoxin Review and Digoxin Label ), VASOLAN (120mg Per Day) (View Vasolan Review and Vasolan Label ), BISOLVON (12mg Per Day) (View Bisolvon Review and Bisolvon Label ), MEDICON (45mg Per Day) (View Medicon Review and Medicon Label ), TERSIGAN (View Tersigan Review and Tersigan Label ). Patient was hospitalized.

5965734-6 | Basedow's Disease, Cardiac Failure, Catheter Related Complication, Goitre, Hyperthyroidism, Neck Pain, Tachycardia
on Nov 18, 2008 Female patient from JAPAN , child 9 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Flolan (View Usage). Patient had the following side effects: basedow's disease, cardiac failure, catheter related complication, goitre, hyperthyroidism, neck pain, tachycardia. Flolan dosage: . During the same period patient was treated with WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), PERSANTINE (View Persantine Review and Persantine Label ), RENIVACE (View Renivace Review and Renivace Label ), VIAGRA (View Viagra Review and Viagra Label ). Patient was hospitalized.

5963348-5 |
Patient was taking Flolan (View Usage). on Nov 19, 2008 from CANADA Additional patient health information: Female patient , 53 years of age, weighting 116.8 lb, . Flolan dosage: .

5959828-9 | C-reactive Protein Increased, Catheter Related Infection, Catheter Site Erythema, Catheter Site Oedema
Adverse event was reported on Nov 18, 2008 by a Female patient taking Flolan (View Usage) (Dosage: ) . Location: JAPAN , 30 years of age, weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: c-reactive protein increased, catheter related infection, catheter site erythema, catheter site oedema. During the same period patient was treated with WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PREDONINE (View Predonine Review and Predonine Label ), DOBUTAMINE HCL (View Dobutamine Hcl Review and Dobutamine Hcl Label ), IMURAN (View Imuran Review and Imuran Label ), JUVELA NICOTINATE (View Juvela Nicotinate Review and Juvela Nicotinate Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), SELBEX (View Selbex Review and Selbex Label ). Patient was hospitalized.

5959822-8 | Goitre, Hyperthyroidism, Supraventricular Tachycardia
on Nov 18, 2008 Female patient from JAPAN , 42 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Flolan (View Usage). Patient had the following side effects: goitre, hyperthyroidism, supraventricular tachycardia. Flolan dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (25mg Per Day) (View Spironolactone Review and Spironolactone Label ), DIGOXIN (.25mg Per Day) (View Digoxin Review and Digoxin Label ), VASOLAN (120mg Per Day) (View Vasolan Review and Vasolan Label ), BISOLVON (12mg Per Day) (View Bisolvon Review and Bisolvon Label ), MEDICON (45mg Per Day) (View Medicon Review and Medicon Label ), TERSIGAN (View Tersigan Review and Tersigan Label ). Patient was hospitalized.

5958072-9 | Autoimmune Thyroiditis, Brain Natriuretic Peptide Increased, Cardiac Failure, Catheter Related Infection, Dyspnoea Exertional, Pneumonia, Pulmonary Haemorrhage
on Nov 18, 2008 Male patient from JAPAN , 22 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Flolan (View Usage). After Flolan was administered, patient had the following side effects: autoimmune thyroiditis, brain natriuretic peptide increased, cardiac failure, catheter related infection, dyspnoea exertional, pneumonia (What is pneumonia?), pulmonary haemorrhage. Flolan dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), CEFAMEZIN (View Cefamezin Review and Cefamezin Label ), AMIKACIN SULFATE (View Amikacin Sulfate Review and Amikacin Sulfate Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), FLUITRAN (View Fluitran Review and Fluitran Label ), HALCION (View Halcion Review and Halcion Label ), MODACIN (View Modacin Review and Modacin Label ), DALACIN (View Dalacin Review and Dalacin Label ). Patient was hospitalized.

5958069-9 | Anaemia, Cardiac Failure, Oedema, Pallor, Palpitations, Tachycardia, Thyroid Disorder, Weight Increased
Patient was taking Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, cardiac failure, oedema, pallor, palpitations, tachycardia, thyroid disorder, weight increased on Nov 14, 2008 from JAPAN Additional patient health information: Female patient , 15 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), pulmonary arterial hypertension and. Flolan dosage: . During the same period patient was treated with WARFARIN POTASSIUM (1mg Per Day) (View Warfarin Potassium Review and Warfarin Potassium Label ), FUROSEMIDE (60mg Per Day) (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (75mg Per Day) (View Spironolactone Review and Spironolactone Label ), DIGOXIN (.25mg Per Day) (View Digoxin Review and Digoxin Label ), SALOBEL (50mg Per Day) (View Salobel Review and Salobel Label ), RENIVACE (2.5mg Per Day) (View Renivace Review and Renivace Label ), VIAGRA (View Viagra Review and Viagra Label ), MYSLEE (View Myslee Review and Myslee Label ). Patient was hospitalized and became disabled.

5957639-1 | Bacteraemia, Fatigue, Micrococcus Infection, Weight Decreased
Adverse event was reported on Oct 22, 2008 by a Female patient taking Flolan (View Usage) (Dosage: Intravenous) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 42 years of age, Patient had the following side effects: bacteraemia, fatigue, micrococcus infection, weight decreased. Patient was hospitalized.

5957638-X | Bacteraemia, Condition Aggravated, Dyspnoea, Escherichia Infection, Micrococcus Infection, Pathogen Resistance, Rales, Urinary Tract Infection
on Oct 22, 2008 Female patient from UNITED STATES , 36 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Flolan (View Usage). After Flolan was administered, patient had the following side effects: bacteraemia, condition aggravated, dyspnoea, escherichia infection, micrococcus infection, pathogen resistance, rales, urinary tract infection (What is urinary tract infection?). Flolan dosage: Ntravenous. Patient was hospitalized.

5957637-8 | Bacteraemia, Micrococcus Infection
on Oct 22, 2008 Male patient from UNITED STATES , 44 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: bacteraemia, micrococcus infection. Flolan dosage: Intravenous. Patient was hospitalized.

5957619-6 | Bacteraemia, Catheter Site Erythema, Catheter Site Pain, Micrococcus Infection
Patient was taking Flolan (View Usage). Patient had the following side effects: bacteraemia, catheter site erythema, catheter site pain, micrococcus infection on Oct 22, 2008 from UNITED STATES Additional patient health information: Female patient , 65 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Flolan dosage: Intravenous. Patient was hospitalized.

5957618-4 | Bacteraemia, Catheter Site Erythema, Dizziness, Hyperhidrosis, Micrococcus Infection, Pain
Adverse event was reported on Oct 22, 2008 by a Male patient taking Flolan (View Usage) (Dosage: Intravenous) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: UNITED STATES , 41 years of age, After Flolan was administered, patient had the following side effects: bacteraemia, catheter site erythema, dizziness (What is dizziness?), hyperhidrosis, micrococcus infection, pain (What is pain?). Patient was hospitalized.

5956512-2 | Blood Pressure Decreased, Emotional Disorder, Temperature Regulation Disorder
on Nov 10, 2008 Male patient from UNITED KINGDOM , 37 years of age, weighting 210.1 lb, was diagnosed with groin pain, hypertension and was treated with Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, emotional disorder, temperature regulation disorder. Flolan dosage: . During the same period patient was treated with HYDROXYCHLOROQUINE SULFATE (200mg Twice Per Day) (View Hydroxychloroquine Sulfate Review and Hydroxychloroquine Sulfate Label ), CO DYDRAMOL (View Co-dydramol Review and Co-dydramol Label ), LOSARTAN POTASSIUM (25mg Variable Dose) (View Losartan Potassium Review and Losartan Potassium Label ).

5955037-8 | Basedow's Disease, Cardiac Failure, Catheter Related Complication, Goitre, Hyperthyroidism, Neck Pain, Tachycardia
on Nov 13, 2008 Female patient from JAPAN , child 9 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Flolan (View Usage). Patient had the following side effects: basedow's disease, cardiac failure, catheter related complication, goitre, hyperthyroidism, neck pain, tachycardia. Flolan dosage: . During the same period patient was treated with WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), PERSANTINE (View Persantine Review and Persantine Label ), RENIVACE (View Renivace Review and Renivace Label ), VIAGRA (View Viagra Review and Viagra Label ). Patient was hospitalized.

5946481-3 |
Patient was taking Flolan (View Usage). on Nov 03, 2008 from CANADA Additional patient health information: Female patient , 52 years of age, . Flolan dosage: .

5935586-9 | Cardiac Failure, Live Birth, Urticaria
Adverse event was reported on Oct 20, 2008 by a Female patient taking Flolan (View Usage) (Dosage: ) . Location: SPAIN , 32 years of age, Patient experienced the following unwanted or unexpected effects: cardiac failure, live birth, urticaria. During the same period patient was treated with KALETRA (View Kaletra Review and Kaletra Label ), EPIVIR (View Epivir Review and Epivir Label ), COMBIVIR (View Combivir Review and Combivir Label ), REVATIO (View Revatio Review and Revatio Label ), ILOPROST (View Iloprost Review and Iloprost Label ).

5931551-6 | Anaemia, Pulmonary Alveolar Haemorrhage, Respiratory Failure
on Oct 20, 2008 Female patient from ITALY , 61 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Flolan (View Usage). Patient had the following side effects: anaemia, pulmonary alveolar haemorrhage, respiratory failure. Flolan dosage: 1.74mg Per Day.

5931539-5 | Anaemia, Haemoglobin Decreased, Pulmonary Alveolar Haemorrhage, Respiratory Failure
on Oct 24, 2008 Female patient from ITALY , 61 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Flolan (View Usage). After Flolan was administered, patient had the following side effects: anaemia, haemoglobin decreased, pulmonary alveolar haemorrhage, respiratory failure. Flolan dosage: 1.74mg Per Day.

5928095-4 | Anaemia, Pulmonary Alveolar Haemorrhage, Respiratory Failure
Patient was taking Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, pulmonary alveolar haemorrhage, respiratory failure on Oct 20, 2008 from ITALY Additional patient health information: Female patient , 61 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Flolan dosage: 1.74mg Per Day.

5925614-9 | Pruritus, Skin Hyperpigmentation
Adverse event was reported on Oct 15, 2008 by a Male patient taking Flolan (View Usage) (Dosage: 22ngkm Per Day) . Location: FRANCE , 65 years of age, weighting 147.7 lb, Patient had the following side effects: pruritus, skin hyperpigmentation. During the same period patient was treated with REVATIO (20mg Three Times Per Day) (View Revatio Review and Revatio Label ), TRACLEER (View Tracleer Review and Tracleer Label ). Patient was hospitalized.

5919368-X | Autoimmune Thyroiditis, Brain Natriuretic Peptide Increased, Cardiac Failure, Catheter Related Infection, Dyspnoea Exertional, Pneumonia, Pulmonary Haemorrhage
on Oct 10, 2008 Male patient from JAPAN , 22 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Flolan (View Usage). After Flolan was administered, patient had the following side effects: autoimmune thyroiditis, brain natriuretic peptide increased, cardiac failure, catheter related infection, dyspnoea exertional, pneumonia (What is pneumonia?), pulmonary haemorrhage. Flolan dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), CEFAMEZIN (View Cefamezin Review and Cefamezin Label ), AMIKACIN SULFATE (View Amikacin Sulfate Review and Amikacin Sulfate Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), FLUITRAN (View Fluitran Review and Fluitran Label ), HALCION (View Halcion Review and Halcion Label ), MODACIN (View Modacin Review and Modacin Label ), DALACIN (View Dalacin Review and Dalacin Label ). Patient was hospitalized.

5913922-7 | Anaemia, Pulmonary Alveolar Haemorrhage, Respiratory Failure
on Oct 06, 2008 Female patient from ITALY , 61 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, pulmonary alveolar haemorrhage, respiratory failure. Flolan dosage: .

5913916-1 | C-reactive Protein Increased, Catheter Related Infection, Catheter Site Erythema, Catheter Site Oedema
Patient was taking Flolan (View Usage). Patient had the following side effects: c-reactive protein increased, catheter related infection, catheter site erythema, catheter site oedema on Oct 06, 2008 from JAPAN Additional patient health information: Female patient , 30 years of age, weighting 132.3 lb, . Flolan dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PREDONINE (View Predonine Review and Predonine Label ), DOBUTAMINE HCL (View Dobutamine Hcl Review and Dobutamine Hcl Label ), IMURAN (View Imuran Review and Imuran Label ), JUVELA NICOTINATE (View Juvela Nicotinate Review and Juvela Nicotinate Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), SELBEX (View Selbex Review and Selbex Label ). Patient was hospitalized.